Meta-Analysis
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 142-154
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.142
Table 3 Characteristics of patients’ studies for vitamin D status in non-alcoholic fatty liver disease
CitationPatel et al[32]Luger et al[30]Barchetta et al[28]Anty et al[27]Dasarthy et al[24]Bril et al[29]Nelson et al[31]Targher et al[26]
Year20162016201220162014201520162007
CountryUnited StatesAustriaItalyFranceUnited StatesUnited StatesUnited StatesItaly
Subjects (M, F)293 (195, 98)50 (10, 40)45 (22, 23)398 (64, 334)187 (51, 136)239 (204, 35)190 (89, 101)120 (80, 40)
PopulationSuspected NAFLD undergoing liver biopsyGastric bypass patientsSuspected NAFLDMorbidly obese referred for bariatric surgeryBiopsy proven NAFLD, normal controlsOverweight patientsBiopsy proven NAFLDBiopsy proven NAFLD
Mean BMI36.1 ± 7.843.8 ± 4.330.5 ± 5.542.8 ± 5.035.7 ± 7.034.6 ± 0.435.6 ± 10.826.3 ± 2.0
SubjectsNAFLDAllNASHAllNAFLDNASHNAFLDNAFLD
Mean ± SD ALT IU/L66.5 ± 51.236.4 ± 20.887.5 ± 46.635.2 ± 24.545.9 ± 30.064.0 ± 4.077.0 ± 48.2105 ± 42.0
SubjectsNAFLDAllNASHMorbidly ObeseNAFLDNASHNAFLDNAFLD
Study designCross sectionalCross sectionalCross sectionalCross sectionalCross sectionalCross sectionalCross sectionalCross sectional
Vitamin D analysisCLIANot describedCLIACLIACLIACLIAGC-MSCLIA
Mean/SD 25(OH)D (ng/mL), (n) subjects27.6 ± 11.815.6 ± 5.622.0 ± 12.419.2 ± 9.021.2 ± 10.421.8 ± 1.020.9 ± 4.020.4 ± 8.8
Mean/SD 25(OH)D (ng/mL) Non-NAFLD Controls27.9 ± 12.8NA52.9 ± 11.0221.5 ± 10/235.7 ± 6.024.5 ± 2.1NA30.0 ± 6.0
P value; NAFLD vs controls0.878NANot significant0.13< 0.010.18NA< 0.001